Fasoracetam, CAS 110958-19-5 Sole GMP Manufacturer
Fasoracetam, CAS 110958-19-5 stable novel crystalline or amorphous form both we have, Fasoracetam, CAS 110958-19-5no any IP problem. Fasoracetam, CAS 110958-19-5 DMF filling, free sample of Fasoracetam, CAS 110958-19-5.
EOS Med Chem have already carried out Fasoracetam, CAS 110958-19-5 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Fasoracetam, CAS 110958-19-5 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Fasoracetam, CAS 110958-19-5 Intermeidates list, most from GMP plant:
Fasoracetam, CAS 110958-19-5 HNMR, MASS, COA, MSDS we have.
Fasoracetam, CAS 110958-19-5, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Fasoracetam, CAS 110958-19-5 stable novel crystalline or amorphous form both we have, Fasoracetam, CAS 110958-19-5no any IP problem. Fasoracetam, CAS 110958-19-5 DMF filling, free sample of Fasoracetam, CAS 110958-19-5.
EOS Med Chem have already carried out Fasoracetam, CAS 110958-19-5 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Fasoracetam, CAS 110958-19-5 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Fasoracetam, CAS 110958-19-5 Intermeidates list, most from GMP plant:
| Fasoracetam, CAS 110958-19-5 Intermediate, 4042-36-8, stock 8.8kg, assay 98.4%, White powder. |
Fasoracetam, CAS 110958-19-5, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
